CXCR3 may play a dual role in CTCL progression, mediating effector T-cell trafficking and promoting an immunosuppressive milieu through immune-cell interactions [41]. Here, CXCR3 is linked to primary cutaneous T-cell non-Hodgkin lymphoma.